PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 136 filers reported holding PUMA BIOTECHNOLOGY INC in Q4 2015. The put-call ratio across all filers is 0.49 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $6,361,000 | +26.3% | 84,397 | +95.6% | 0.14% | +24.8% |
| Q2 2015 | $5,037,000 | -42.4% | 43,141 | +16.4% | 0.11% | -40.4% |
| Q1 2015 | $8,749,000 | +700.5% | 37,052 | +541.3% | 0.18% | +662.5% |
| Q4 2014 | $1,093,000 | -13.9% | 5,778 | +8.5% | 0.02% | -14.3% |
| Q3 2014 | $1,270,000 | -1.1% | 5,323 | -72.6% | 0.03% | 0.0% |
| Q2 2014 | $1,284,000 | +3.8% | 19,461 | +63.8% | 0.03% | +3.7% |
| Q1 2014 | $1,237,000 | -25.8% | 11,879 | -26.2% | 0.03% | -22.9% |
| Q4 2013 | $1,666,000 | – | 16,088 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HARVARD MANAGEMENT CO INC | 600,000 | $45,216,000 | 3.56% |
| Avalon Global Asset Management LLC | 32,900 | $2,479,000 | 1.79% |
| CORNERSTONE CAPITAL MANAGEMENT LLC | 495,145 | $37,314,000 | 1.58% |
| BB BIOTECH AG | 521,991 | $39,337,000 | 1.25% |
| WEATHERBIE CAPITAL, LLC | 137,041 | $10,327,000 | 1.20% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 5,686,668 | $428,527,000 | 1.19% |
| TOBAM | 318,384 | $23,994,000 | 0.94% |
| Orbimed Advisors | 1,195,500 | $90,093,000 | 0.91% |
| Capital International Sarl | 109,405 | $8,245,000 | 0.74% |
| CAPITAL INTERNATIONAL LTD /CA/ | 145,697 | $10,980,000 | 0.73% |